E-drug: Prednisolone in veterinary intramammary preparations
The Medicines Control Authority of Zimbabwe is responsible for the
registration of human and veterinary medicines as well as licensing
of persons and premises involved in handling medicines.
The Authority is currently reviewing the acceptability of inclusion
of prednisolone in veterinary intramammary preparations (for infusion
into the teat canal of cattle) for treatment of mastitis. Applicants
intending to register products containing predisolone in combination
with antibiotics have been requested to provide justification for
inclusion of prednisolone. The therapeutic advantage for inclusion
of prednisolone was found to be questionable, with some researchers
supporting its use; and others discouraging its use.
We would appreciate if:
- other regulatory authorities could advise whether such combination
(prednisolone + antibiotics) intramammary products are approved in
- experts in the field of mastitis treatment could guide us with
respect to use of prednisolone infusions into the teat canal.
Thank you in advance.
William Wekwete (Dr) (BVSc)
Medicines Control Authority of Zimbabwe
P O Box UA 559, Union Avenue
Tel: 263-4-736981/5, 708255, 792165
Send mail for the `E-Drug' conference to `email@example.com'.
Mail administrative requests to `firstname.lastname@example.org'.
For additional assistance, send mail to: `email@example.com'.